3 Stocks Moving Up – RAC, MGV and KNM

Race Oncology Ltd (ASX: RAC)

Race Oncology Ltd (ASX: RAC) recently announced that it has executed a services agreement with Biosynergy Partners LLC to pursue licensing and other deals for Bisantrene.  Biosynergy is a transaction consulting business owned by Dr. John Cullity, a non-executive director of RAC. Following this news, the share price of the company witnessed an intraday increase of 80.952 percent as on 1 November 2018. In the recently announced September quarter report, the company reported that the net cash used in operations was $8.38 million which came lower than what was projected, mainly due to personnel and other cost savings. The Cash reserves at the end of the quarter were $2.845 million, which is projected to be enough to cover expenses for the remainder of the current financial year. The Company continues to pursue NPP usage in Europe and remains committed to achieving contemporary usage of Bisantrene by clinicians. In the last six months, the share price of the company decreased by 62.50 percent as on 31 October 2018. RAC’s shares traded at $0.190 with a market capitalization of circa $8.11 million as on 1 November 2018.  [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

Musgrave Minerals Limited (ASX: MGV)

Musgrave Minerals Limited (ASX: MGV) is an Australian resources company which is having significant potential to extend the existing mineralization at Break of Day and Lena and also to discover new high-grade gold mineralization within the Project area. The recent high-grade gold discovery at Lake Austin North highlights the huge exploration potential under the salt lakes to the north of Break of Day/Lena. At the end of the September quarter, the company was having cash of 4.0 million. In FY 2018, the company reported the loss of $189,475 which was $5,240,475 in FY 2017. The net cash used in operating activities was $115,306 in FY 2018. As at 30 June 2018, the company was having net assets of $16.08 million including cash and cash equivalents of $5.23 million. On 1 November 2018, the company’s shares increased by 14.103 percent. In the last six months, the share price of the company increased by 30 percent as on 31 October 2018. MGV’s shares traded at $0.089 with a market capitalization of circa $25.51 million as on 1 November 2018 (AEST 4:00 PM).

KNeoMedia Limited (ASX: KNM)

KNeoMedia Limited (ASX: KNM) is an educational publishing company which has greatly strengthened its operations and sales pipeline in four key markets, the United States, the United Kingdom, the Philippines, and Australia. On 31 October 2018, the company released its September quarter update, following which the share price of the company increased by 50 percent in a single day. KNeoMedia is currently having healthiest sales pipeline in its history, across all markets, and the company is now entering a period of converting this pipeline into actual sales. In the September quarter, the cash outflows increased by approximately $290,000. In FY 2018, the net loss for the year was $2,349,082 which was an increase from the loss of $1,285,911 in FY 2017, the increase was primarily due to the non-cash share-based payment expenses of $660,833 from the issue of shares under the Company’s Long-Term Incentive Plan for nil cash consideration and funds deployed for planned expansion of the Company into new markets. In the last six months, the share price of the company decreased by 75.76 percent as on 31 October 2018. KNM’s shares traded at $0.024 with a market capitalization of circa $10.22 million as on 1 November 2018 (AEST 4:00 PM).


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report